Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
By Jahnavi Nidumolu and Krystal Hu (Reuters) -Twitter’s cash flow remains negative because of a...
MOSCOW (Reuters) – President Vladimir Putin said Russia had a “sufficient stockpile” of cluster bombs...
In the world of finance, the adage that ‘money talks’ rings particularly true when...
(This July 15 story has been refiled to fix typographical errors in paragraphs 3 and...
By Yew Lun Tian BEIJING (Reuters) – A Chinese naval flotilla set off on Sunday...
By Stephen Nellis, Andrea Shalal and Karen Freifeld (Reuters) – The chief executives of Intel...
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...
By Sheila Dang and Krystal Hu (Reuters) -Elon Musk on Friday said the purpose of...
(Corrects 2nd paragraph to make it “June 2022” instead of “last month”) By Curtis Williams...